Halozyme Therapeutics (HALO) trading halted with news pending
Tweet
Share
E-mailGet Alerts HALO Hot Sheet
Join SI Premium – FREE
Halozyme Therapeutics (Nasdaq: HALO) trading halted with news pending
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
- Barclays flags an "attractive entry point" in this pharma stock
- Halozyme adds biotech executive Appelhans to its board
Create E-mail Alert Related Categories
Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
